Vivo Capital as of Dec. 31, 2017
Portfolio Holdings for Vivo Capital
Vivo Capital holds 30 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 15.2 | $71M | 1.8M | 40.06 | |
| Biohaven Pharmaceutical Holding | 11.4 | $53M | 2.0M | 26.98 | |
| Aclaris Therapeutics (ACRS) | 8.7 | $41M | 1.6M | 24.66 | |
| Apellis Pharmaceuticals (APLS) | 6.8 | $32M | 1.5M | 21.70 | |
| Codexis (CDXS) | 5.5 | $26M | 3.1M | 8.35 | |
| Eiger Biopharmaceuticals | 5.3 | $25M | 1.8M | 13.95 | |
| Nabriva Therapeutics | 5.2 | $24M | 4.1M | 5.98 | |
| Aimmune Therapeutics | 5.2 | $24M | 644k | 37.82 | |
| Kala Pharmaceuticals | 4.6 | $21M | 1.2M | 18.49 | |
| Advanced Accelerat spon ads each rep 2 ord | 4.4 | $20M | 249k | 81.62 | |
| Strongbridge Bioph shs usd | 3.8 | $18M | 2.5M | 7.25 | |
| Verona Pharma Plc ads (VRNA) | 3.8 | $18M | 1.5M | 11.87 | |
| Kadmon Hldgs | 2.6 | $12M | 3.3M | 3.62 | |
| Selecta Biosciences | 2.4 | $11M | 1.1M | 9.81 | |
| Amyris | 2.3 | $11M | 2.8M | 3.75 | |
| Sierra Oncology | 1.9 | $9.1M | 2.4M | 3.73 | |
| Soleno Therapeutics | 1.6 | $7.3M | 4.0M | 1.80 | |
| Zai Lab (ZLAB) | 1.4 | $6.7M | 318k | 21.23 | |
| Aurinia Pharmaceuticals (AUPH) | 1.2 | $5.5M | 1.2M | 4.53 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $5.5M | 164k | 33.25 | |
| Foamix Pharmaceuticals | 1.1 | $5.1M | 855k | 6.01 | |
| Zogenix | 0.9 | $4.2M | 105k | 40.05 | |
| Agile Therapeutics | 0.9 | $4.1M | 1.5M | 2.69 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $2.9M | 300k | 9.75 | |
| Trevena | 0.6 | $2.8M | 1.7M | 1.60 | |
| Crispr Therapeutics (CRSP) | 0.5 | $2.3M | 99k | 23.48 | |
| Sunesis Pharmaceuticals Inc Ne | 0.4 | $1.8M | 500k | 3.69 | |
| Biopharmx | 0.3 | $1.5M | 14M | 0.11 | |
| Akari Therapeutics | 0.3 | $1.5M | 346k | 4.33 | |
| Soleno Therapeutics, Inc. warrant | 0.0 | $26k | 189k | 0.14 |
